The FDA went against an external advisory board and approved Biogen’s Aduhelm drug, the first treatment for Alzheimer’s in almost 20 years. Despite its possible […]
Continue readingThe FDA went against an external advisory board and approved Biogen’s Aduhelm drug, the first treatment for Alzheimer’s in almost 20 years. Despite its possible […]
Continue reading